In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Poster Session 3: Chronic Heart Failure – Treatment
Session

Event : Heart Failure 2018

Topic : Other

  • Session type : Poster Session
  • Date : 28 May 2018
  • Time : 08:30 - 18:00

39 presentations in this session

Tertiary heart failure care in the netherlands: what is the added value

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : M Vester (Amsterdam,NL)

The protective effect of beta-blockers in 3,278 advanced heart failure patients treated with continuous inotropes

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : O Havakuk (Tel Aviv,IL)

The benefits of ivabradine in the management of angina pectoris and heart failure.

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : R ZAINAB (Tanger,MA)

Anti diabetic therapy in patients with heart failure and type 2 diabetes mellitus in general population.

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : I Fomin (Nizhni Novgorod,RU)

Design and rationale of the EMPagliflozin outcome trial in patients with chronic heart failure (EMPEROR-Reduced)

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : F Zannad (Vandoeuvre,FR)

Sacubitril/valsartan and circulating catecholamine levels during a 6 month follow-up in stable heart failure patients

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : G Chalikias (Alexandroupolis,GR)

Safety of ambulatory intermittent cycles of levosimendan in patients with advanced heart failure listed for heart transplant

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : J De Juan Baguda (Madrid,ES)

Oral diuretics in very intensive treatment, an early intervention in outpatients with heart failure. DIVINE STUDY

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : EJJ Chuquiure (Mexico City,MX)

Warm water immersion in patients with chronic heart failure: A pilot study

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : P Shah (London,GB)

Identifying accelerometers to measure physical activity in patients with heart failure

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : L Klompstra (Norrkoping,SE)

Assesment of symptom limited stair climbing test efficacy in patients with chronic heart failure

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : B Alkan (Konya,TR)

Haemodynamic parameter analysis during impella-protected pci in high risk patients with reduced ejection fraction

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : D D'amario (Rome,IT)

Does deactivation of a site's surgical cardiac transplant program affect the long-term survival of its recipients?

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : W Parker (Sheffield,GB)

Is glycated hemoglobin a prognosis factor in Heart Transplant Recipients with diabetes?

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : A Grande Trillo (Sevilla,ES)

Predisposing factors for development of acute right ventricular failure after heart transplantation

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : J Ljubas Macek (Zagreb,HR)

Assessing and comparing the need for palliative care in different advanced HF cohorts

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : M Rybczynski (Hamburg,DE)

Clinical impact of Sacubitril/valsartan in patients with heart failure with reduced ejection fraction and management of loop diuretic during follow up

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : M Fernandez de Sanmamed Giron (Las Palmas De Gran Canaria,ES)

"The patient will see you now". Use of a clinic proforma to help clinicians identify the heart failure patients' agenda

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : AK Nightingale (Bristol,GB)

Incidence and factors related to vasoplegia in the early postoperatory period of orthotopic heart transplantation

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : R Lopez Vilella (Valencia,ES)

Early effects of empagliflozin on exercise tolerance in patients with heart failure: a pilot study

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : A Mollar (Valencia,ES)

Possibilities of differentiated immunosuppressive therapy in patients after orthotopic heart transplantation

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : A Kurlianskaya (Minsk,BY)

The Effect of Interventricular Delay on Acute Hemodynamic Response with Cardiac Resynchronization Therapy

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : N Yu (St Paul,US)

Evaluation of the optimal energy, protein, fat and carbohydrate needs in obese patients with chronic heart failure.

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : T Zaletova (Moscow,RU)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are